Hitachi Develops AI Technology to Support Pre-preparation for Expert Panels in Cancer Genomic Medicine
NQ Score
50/100
AI Summary (NQ-processed)
Hitachi has developed AI technology to support the pre-preparation of expert panels for cancer genomic medicine.
AI analysis data is not yet available.
Frequently Asked Questions
- Q: Which organizations collaborated to develop the new AI technology for cancer genomic medicine?
- A: Tohoku University Hospital, Hitachi, and Hitachi High-Tech collaborated to develop this AI technology.
- Q: What is the primary purpose of the AI technology developed by the organizations?
- A: The technology supports the pre-preparation of Expert Panels for the medical interpretation of genetic test results.
- Q: What kind of information does this technology refer to when presenting points for discussion?
- A: It refers to past physician comments, related knowledge, and literature databases to present confirmation points.
- Q: Where is the AI system designed to operate to ensure that sensitive information is not transmitted externally?
- A: The system is designed to operate on personal computers within the hospital to avoid external transmission of sensitive data.
- Q: What percentage of the points presented by the AI technology matched the Expert Panel's review results in the evaluation?
- A: In the evaluation using past cases, over 80 percent of the points presented by the technology matched the review results.